syngeneic bone marrow transplantation
Sponsors
Temple University, Barbara Ann Karmanos Cancer Institute, Herbert Irving Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Fred Hutchinson Cancer Center
Conditions
Autoimmune DiseaseAutoimmune Nervous System DisorderAutologous Transplant AutoimmuneCIDP TransplantCentral Nervous System VasculitisCerebellar DegenerationChronic Inflammatory Demyelinating PolyneuropathyHCT for Neurologic Autoimmune Disorders
Phase 2
Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
CompletedNCT00002521
Start: 1993-02-28End: 2000-02-29Updated: 2010-10-01
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
CompletedNCT00002522
Start: 1993-02-28End: 2002-02-28Updated: 2010-10-01
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
NCT00008307
Start: 1998-04-30Target: 52Updated: 2014-01-06
Multiple Therapies in Treating Patients With Advanced Neuroblastoma
CompletedNCT00040872
Start: 2000-06-30End: 2007-01-31Updated: 2013-03-07
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
CompletedNCT00002552
Start: 1993-10-31End: 2003-10-31Target: 40Updated: 2013-04-09
Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
CompletedNCT00002547
Start: 1987-08-31End: 2003-10-31Updated: 2012-08-07
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Active, not recruitingNCT00716066
Start: 2008-06-01End: 2030-01-31Updated: 2026-02-27
Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma
CompletedNCT00793572
Start: 2008-10-31End: 2016-10-31Updated: 2020-01-22